Amsbio has introduced Genein - a transfection reagent designed to transfect stem cells and primary cells.
The company claims that comparative studies against other commercially available reagents show Genein to be superior in transfection efficiency with minimum cytotoxicity.
Delivery of nucleic acids into mammalian cells is often a critical task in the area of cell and molecular biology.
According to Amsbio, stem cells and primary cells have traditionally proven to be very difficult to transfect.
Genein is a novel cationic transfection reagent formulated from proprietary compounds that are chemically defined and are of animal-free origin.
Tested on a wide range of commonly used cell lines and operating over a wide dynamic range, Genein offers minimal optimisation to achieve superior expression results.
Genein transfection reagent forms part of a range of stem cell qualified products, including leukemia inhibitory factor (mLIF) and fibroblast feeder cells, which offer reproducible performance and high consistency from lot to lot.